Skip to search formSkip to main contentSkip to account menu

Dexamethasone 0.7 MG Drug Implant [Ozurdex]

Known as: Ozurdex 0.7 MG Intravitreal Drug Implant, dexamethasone 0.7 mg INTRAVITREAL IMPLANT [OZURDEX] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Purpose: To investigate predictors of success, visual outcomes, and complications of intravitreal ocriplasmin for the treatment… 
2016
2016
ZusammenfassungFallbeschreibungEs wird über den Fall einer 50-jährigen Patientin berichtet, die bei fokaler vitreomakulärer… 
Review
2015
Review
2015
Touch MEDical MEDia Currently four pharmacotherapies have been approved in the US for the treatment of diabetic macular edema… 
2014
2014
Purpose To report two cases of desegmentation or fracture of the Ozurdex implant observed immediately after routine intravitreal… 
2014
2014
Purpose To evaluate the long‐term efficacy and safety of intravitreal implant of 0,7mg dexamathasone (ozurdex®) in diabetic… 
2013
2013
Retinitis pigmentosa denotes a heterogeneous group of rare genetic diseases in which both rods and cones eye are damaged. It is a… 
2012
2012
PURPOSE The purpose of this study was to report a novel complication of Ozurdex implantation in which the implant migrates into… 
2012
2012
ZusammenfassungEine 63-jährige Patientin mit Venenastthrombose und Makulaödem stellte sich Anfang 2011 erstmalig nach… 
2011
2011
Purpose To report our experience with sustained-release dexamethasone 0.7 mg intravitreal implant (Ozurdex®; Allergan, Inc…